FDA NDC Directory · JSON-LD · Markdown

ONDANSETRON

NDC 51662-1514 · HUMAN PRESCRIPTION DRUG · TABLET, ORALLY DISINTEGRATING

Labeler / ManufacturerHF Acquisition Co LLC, DBA HealthFirst
Marketing categoryAbbreviated NDA (generic) · App ANDA090469
Dosage form / routeTABLET, ORALLY DISINTEGRATING · ORAL
Active ingredientsONDANSETRON (4 mg/1)
Marketing started20200331
Package count2

External sources

Source: openFDA. Public-domain (CC0).